FK778
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Kidney Transplantation
Conditions
Kidney Transplantation, Renal Transplantation, Transplantation, Renal, Transplantation, Kidney, Grafting, Kidney
Trial Timeline
Sep 1, 2003 → Oct 1, 2005
NCT ID
NCT00189735About FK778
FK778 is a phase 2 stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00189735. Target conditions include Kidney Transplantation, Renal Transplantation, Transplantation, Renal.
What happened to similar drugs?
20 of 20 similar drugs in Kidney Transplantation were approved
Approved (20) Terminated (1) Active (0)
✅basiliximab + rabbit anti-thymocyte globulin + tacrolimus + alemtuzumab + mycophenolate mofetil + steroidsAstellas PharmaApproved
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00104338 | Phase 2 | Terminated |
| NCT00282230 | Phase 2 | Terminated |
| NCT00189735 | Phase 2 | Completed |
| NCT00451932 | Phase 2 | Completed |
Competing Products
20 competing products in Kidney Transplantation